LAVA Therapeutics N.V.
USD1.74
-0.07 (-3.87%)
CEO
Stephen Allen Hurly
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
Open
$1.74
Prev. Close
$1.74
Day Low
$1.74
Day High
$1.74
52W Low
$0.85
52W High
$2.00
Market Cap
$0.05B
Volume
0.29M
| -1.0 |
| 31 Dec 2022 | FY | 100.0% | -164.5% | -37.1% | -22.2% | 0.06 | 6.40 | -2.8 |
| 31 Dec 2021 | FY | 100.0% | -791.7% | -35.8% | -30.4% | 0.04 | 12.14 | -2.6 |
| 31 Dec 2020 | FY | -319.0% | -425.1% | -209.0% | -77.7% | 0.54 | 2.48 | -22.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -165.8% | -110.1% | 0.30 | 5.35 | -27.2 |
| -1.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -13.5% | -4.9% | 0.01 | 6.73 | -2.5 |
| 31 Dec 2024 | Q4 | -392.0% | -79.6% | -14.3% | -4.9% | 0.19 | 4.40 | -1.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -37.3% | -14.8% | 0.19 | 5.36 | -0.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -19.4% | -9.0% | 0.14 | 6.39 | -1.5 |
| 31 Mar 2024 | Q1 | 100.0% | -8.7% | -1.2% | -0.6% | 0.12 | 7.42 | -37.1 |
| 31 Dec 2023 | Q4 | 56.4% | -1840.8% | -12.7% | -6.4% | 0.12 | 6.64 | -1.6 |
| 30 Sept 2023 | Q3 | 81.1% | -16671.7% | -16.2% | -8.0% | 0.11 | 5.20 | -1.1 |
| 30 Jun 2023 | Q2 | 53.5% | -247.1% | -19.9% | -10.4% | 0.11 | 5.31 | -1.1 |